Neonatal Alloimmune Thrombocytopenia
Basics
DESCRIPTION
Neonatal alloimmune thrombocytopenia (NAIT) is one of the major causes of severe thrombocytopenia in the newborn.
- Analogous to ABO/Rh incompatibility but involves platelets instead of RBCs
- Presents with bleeding complications including petechiae, bruising, mucosal bleeding, and/or intracranial hemorrhage (ICH) that can occur in utero
EPIDEMIOLOGY
1:1,000 live births
GENERAL-PREVENTION
In pregnancies known to be at risk of NAIT, maternal treatment with IVIG in the antenatal period can be considered.
PATHOPHYSIOLOGY
Antibody-mediated platelet destruction
ETIOLOGY
Maternal IgG antibodies, directed against paternally inherited platelet-specific antigens in the fetus, cross the placenta, enter the fetal circulation, and attack fetal platelets.
- HPA-1a (formerly PLA-1) incompatibility is by far the most common cause of NAIT in those of Caucasian ancestry, accounting for ~75% of cases. The disease happens when the mother is HPA-1a negative (HPA 1b/1b) and father is HPA-1a positive (HPA 1a/1a or 1a/1b). If the fetus inherits HPA-1a from father, maternal exposure to HPA-1a–positive fetal platelets during pregnancy causes mother to generate anti–HPA-1a IgG antibodies. Anti–HPA-1a antibodies crosses the placenta and causes platelet destruction.
- Other common antigens implicated in NAIT include HPA-2, HPA-3, HPA-5, HPA-9, and HPA-15.
- HPA-4 incompatibility accounts for the majority of cases in Asian populations.
- At least 23 other low-frequency antigens have been reported in a small fraction of cases.
- HPA-1a–negative mothers who are HLA-DRB3*0101 positive are far more likely to develop antibodies than those who are DRB3 negative.
- The role of HLA platelet antigens in NAIT is controversial.
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Cabana, Michael D., editor. "Neonatal Alloimmune Thrombocytopenia." Select 5-Minute Pediatrics Topics, 7th ed., Wolters Kluwer Health, 2015. Medicine Central, im.unboundmedicine.com/medicine/view/Select-5-Minute-Pediatric-Consult/14090/all/Neonatal_Alloimmune_Thrombocytopenia.
Neonatal Alloimmune Thrombocytopenia. In: Cabana MDM, ed. Select 5-Minute Pediatrics Topics. Wolters Kluwer Health; 2015. https://im.unboundmedicine.com/medicine/view/Select-5-Minute-Pediatric-Consult/14090/all/Neonatal_Alloimmune_Thrombocytopenia. Accessed December 18, 2024.
Neonatal Alloimmune Thrombocytopenia. (2015). In Cabana, M. D. (Ed.), Select 5-Minute Pediatrics Topics (7th ed.). Wolters Kluwer Health. https://im.unboundmedicine.com/medicine/view/Select-5-Minute-Pediatric-Consult/14090/all/Neonatal_Alloimmune_Thrombocytopenia
Neonatal Alloimmune Thrombocytopenia [Internet]. In: Cabana MDM, editors. Select 5-Minute Pediatrics Topics. Wolters Kluwer Health; 2015. [cited 2024 December 18]. Available from: https://im.unboundmedicine.com/medicine/view/Select-5-Minute-Pediatric-Consult/14090/all/Neonatal_Alloimmune_Thrombocytopenia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Neonatal Alloimmune Thrombocytopenia
ID - 14090
ED - Cabana,Michael D,
BT - Select 5-Minute Pediatrics Topics
UR - https://im.unboundmedicine.com/medicine/view/Select-5-Minute-Pediatric-Consult/14090/all/Neonatal_Alloimmune_Thrombocytopenia
PB - Wolters Kluwer Health
ET - 7
DB - Medicine Central
DP - Unbound Medicine
ER -